Effects of the novel beta-adrenergic partial agonist alifedrine on cardiac performance in dogs with acute ischemic left ventricular failure

J Cardiovasc Pharmacol. 1989 Jul;14(1):103-8. doi: 10.1097/00005344-198907000-00018.

Abstract

Acute ischemic left ventricular failure was induced in dogs by coronary embolization with plastic microspheres, resulting in reduced cardiac output (CO), increased left ventricular end-diastolic pressure (LVEDP), pulmonary capillary pressure (PCP), and total peripheral resistance (TPR). Intravenous (i.v.) administration of alifedrine, a beta-adrenergic partial agonist (0.3 mg/kg as bolus and 0.3 mg/kg/h as infusion), significantly improved performance of the failing heart. Left ventricular contractility was increased up to 50%, heart rate (HR) up to 28%, and CO up to 30%. LVEDP, PCP, and TPR were markedly decreased. Myocardial oxygen consumption was increased only to a minor degree despite the positive inotropic effect; coronary flow was augmented up to 26%. Thus, alifedrine in this model markedly improved left ventricular function by balanced stimulation of the myocardium and reduction of pre- and afterload.

MeSH terms

  • Acute Disease
  • Adrenergic beta-Antagonists / pharmacology*
  • Anesthesia
  • Animals
  • Blood Pressure / drug effects
  • Coronary Disease / physiopathology*
  • Dogs
  • Female
  • Heart / drug effects*
  • Heart Failure / drug therapy
  • Heart Failure / physiopathology
  • Heart Rate / drug effects
  • Hemodynamics / drug effects
  • Male
  • Microspheres
  • Oxyfedrine / analogs & derivatives
  • Oxyfedrine / pharmacology*
  • Propiophenones / pharmacology*

Substances

  • Adrenergic beta-Antagonists
  • Propiophenones
  • Oxyfedrine
  • alifedrine